The reactivity of various human sera with mumps complement fixation antigens. 1948

G HENLE, and S HARRIS, and W HENLE

Human sera taken at various stages of mumps have been analyzed in regard to their reactivity with two serologically distinct complement fixation antigens which were derived from the infected chick embryo. Antibodies to the soluble or S antigen appear earlier in the disease and, as a rule, reach high levels before antibodies against the virus-bound or V antigen commence to rise. In early convalescence, both antibodies reach high levels. Subsequently antibodies against the S antigen decrease usually at a faster rate than those against V, so that after a period of several years, frequently only anti-V may be left. These findings were found helpful in diagnostic procedures. The use of both the V and S antigens has permitted the early diagnosis of manifestations of mumps in the absence of parotitis, such as meningoencephalitis, since the finding of high levels of anti-S and of low titers of, or no, anti-V is considered diagnostically significant for the first few days of illness. For the determination of resistance the use of the V antigen appears more useful. Following vaccination or skin testing, antibodies against both antigens may develop; those against V increase more regularly and to higher titers than those against S.

UI MeSH Term Description Entries
D009107 Mumps An acute infectious disease caused by RUBULAVIRUS, spread by direct contact, airborne droplet nuclei, fomites contaminated by infectious saliva, and perhaps urine, and usually seen in children under the age of 15, although adults may also be affected. (From Dorland, 28th ed) Parotitis, Epidemic,Epidemic Parotitides,Epidemic Parotitis,Parotitides, Epidemic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000906 Antibodies Immunoglobulin molecules having a specific amino acid sequence by virtue of which they interact only with the ANTIGEN (or a very similar shape) that induced their synthesis in cells of the lymphoid series (especially PLASMA CELLS).
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies
D000941 Antigens Substances that are recognized by the immune system and induce an immune reaction. Antigen

Related Publications

G HENLE, and S HARRIS, and W HENLE
February 1968, Journal of the National Cancer Institute,
G HENLE, and S HARRIS, and W HENLE
August 1978, Cancer research,
G HENLE, and S HARRIS, and W HENLE
January 1969, Bulletin de l'Academie polonaise des sciences. Serie des sciences biologiques,
G HENLE, and S HARRIS, and W HENLE
June 1969, The Tohoku journal of experimental medicine,
G HENLE, and S HARRIS, and W HENLE
June 1985, Transplantation,
G HENLE, and S HARRIS, and W HENLE
June 1966, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
G HENLE, and S HARRIS, and W HENLE
January 1956, Wiadomosci parazytologiczne,
G HENLE, and S HARRIS, and W HENLE
July 1955, Praxis,
G HENLE, and S HARRIS, and W HENLE
November 1958, Zeitschrift fur arztliche Fortbildung,
Copied contents to your clipboard!